The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
The Effect of the Medicare Part D Prescription Benefit on Drug Utilization and Expenditures
Abstract
BACKGROUND: Information about the effect of the Medicare Part D Prescription Drug Benefit on drug utilization and expenditures is limited. OBJECTIVE: To estimate changes in prescription utilization and out-of-pocket expenditures attributable to Part D among a sample of persons eligible for the benefit. DESIGN: Generalized estimating equations were used to estimate changes in expenditures and utilization among beneficiaries. A control group was included to control for secular trends unrelated to the Part D benefit. SETTING: National pharmacy chain representing approximately 15% of all U.S. retail pharmacy sales. PARTICIPANTS: Persons age 66 to 79 years (those eligible for Part D) and a control group of persons age 60 to 63 years (those ineligible for Part D). The final sample represented approximately 5.1 million unique beneficiaries and 1.8 million unique control individuals. MEASUREMENTS: Prescription utilization (measured in pill-days) and out-of-pocket expenditures, as determined from pharmacy claims from September 2004 to April 2007. RESULTS: During the penalty-free Part D enrollment period (January 2006 to May 2006), average monthly drug utilization increased by 1.1% (95% CI, 0.5% to 1.7%; P < 0.001) and out-of-pocket expenditures decreased by 8.8% (CI, 6.6% to 11.0%; P < 0.001). After enrollment stabilized (June 2006 to April 2007), average monthly drug utilization increased by 5.9% (CI, 5.1% to 6.7%; P < 0.001) and out-of-pocket expenditures decreased by 13.1% (CI, 9.6% to 16.6%; P = 0.003). Compared with eligible nonenrollees, enrollees had higher out-of-pocket expenditures and utilization at baseline but experienced significantly larger decreases in expenditures and increases in utilization after enrollment. LIMITATIONS: Analyses were limited to claims within 1 pharmacy chain. The effect of the "doughnut hole" and the effect of changes on clinical outcomes were not evaluated. CONCLUSION: The Medicare Part D prescription benefit resulted in modest increases in average drug utilization and decreases in average out-of-pocket expenditures among Part D beneficiaries. Further research is needed to examine patterns among other beneficiaries and to evaluate the effect of these changes on health outcomes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Estimating causal effects of treatments in randomized and nonrandomized studies
Rubin, D. B. (1974) · Journal of Educational Psychology · doi:10.1037/h0037350 · Cited by 9,436
Statistics and Causal Inference
Holland, P. W. (1986) · Journal of the American Statistical Association · doi:10.1080/01621459.1986.10478354 · Cited by 5,293 · cited 1×
“Thus, we sought to estimate the effect of Part D on expenditures and utilization netting out contemporaneous changes to the outcome variable due to factors unrelated to Part D (15, 16).”
BackgroundGeneralized modeling approaches to risk adjustment of skewed outcomes data
Manning, W. G., Basu, A., & Mullahy, J. (2005) · Journal of Health Economics · doi:10.1016/j.jhealeco.2004.09.011 · Cited by 760
Self-citation
Cited by
Comparison Friction: Experimental Evidence from Medicare Drug Plans
Kling, J. R., Mullainathan, S., Shafir, E., Vermeulen, L. C., & Wrobel, M. V. (2012) · The Quarterly Journal of Economics · doi:10.1093/qje/qjr055 · Cited by 340
Pharmaceutical policies: effects of cap and co-payment on rational use of medicines.
Luiza, V. L., Chaves, L. A., Silva, R. M., Emmerick, I. C. M., Chaves, G. C., Fonseca de Araújo, S. C., Moraes, E. L., & Oxman, A. D. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007017.pub2 · Cited by 102
The anticipatory effects of Medicare Part D on drug utilization
Alpert, A. (2016) · Journal of Health Economics · doi:10.1016/j.jhealeco.2016.06.004 · Cited by 69
Metadata
- Authors
- Yin, W., Basu, A., Zhang, J. X., Rabbani, A., Meltzer, D. O., & Alexander, G. C.
- Venue
- Annals of Internal Medicine
- Publisher
- American College of Physicians
- Published
- 2008-02-05
- Volume
- 148
- Issue
- 3
- Pages
- 169-177
- ISSN
- 0003-4819 (ISSN-L)
- 1539-3704
- OpenAlex
- W2075180841
- Cited by
- 202
- References
- 3
- FWCI
- 62.94
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Effect of the Medicare Part D Prescription Benefit on Drug Utilization and Expenditures. https://app.cochat.ai/papers/10.7326/0003-4819-148-3-200802050-00200
- The paper
- Yin, W., Basu, A., Zhang, J. X., Rabbani, A., Meltzer, D. O., & Alexander, G. C. (2008). The Effect of the Medicare Part D Prescription Benefit on Drug Utilization and Expenditures. Annals of Internal Medicine. https://doi.org/10.7326/0003-4819-148-3-200802050-00200
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.